Interventions, such as annual screening by breast magnetic resonance imaging (MRI), are available for women harboring deleterious BRCA1 or BRCA2 variants to facilitate early detection of breast cancer and active risk reduction via risk-reducing surgery, such as bilateral mastectomy and salpingo-oophorectomy [2]. The gene discussed is BRCA2; the disease is breast carcinoma.